Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
129,821,091
-
Total 13F shares
-
34,704,784
-
Share change
-
-13,210,915
-
Total reported value
-
$20,548,205
-
Put/Call ratio
-
0%
-
Price per share
-
$0.5921
-
Number of holders
-
50
-
Value change
-
-$8,230,826
-
Number of buys
-
30
-
Number of sells
-
49
Institutional Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q2 2025
As of 30 Jun 2025 PROKIDNEY CORP. - Ordinary Shares (PROK) had 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,704,784 shares of stock of the company.
Largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Bleichroeder LP, BlackRock, Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Brown University, Hennion & Walsh Asset Management, Inc., and BANK OF AMERICA CORP /DE/.
This table shows 50 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.